EP1209157A1 — Heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and related compounds
Assigned to Pfizer Inc · Expires 2002-05-29 · 24y expired
What this patent protects
The present invention relates to novel heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and, specifically, to compounds of formula (I), wherein W, R 1 , R 3 , P and A are as defined in the specification, and to intermediates used in the synthe…
USPTO Abstract
The present invention relates to novel heteroarylamino and heteroarylsulfonamido substituted 3-benzylaminomethyl piperidines and, specifically, to compounds of formula (I), wherein W, R 1 , R 3 , P and A are as defined in the specification, and to intermediates used in the synthesis of such compounds. The novel compounds of formula (I) are useful in the treatment of inflammatory and central nervous system disorders, as well as other disorders.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.